Log in

2020 CMA Regulatory Seminar

  • 29 Apr 2020
  • 9:00 AM - 5:00 PM
  • Online TBC


CMA Regulatory Forum 2020
Actioning the New Regulatory Framework for Complementary Medicines

Click here to view the program

COVID-19 Update

After monitoring the evolving situation around coronavirus (COVID-19) and the latest updates from the Australian Government regarding restrictions on gatherings of more than 100 people, social distancing and travel restrictions, we have made the decision that the CMA Regulatory Forum will no longer take place as a face to face event on 29 April 2020. The wellbeing and safety of our staff, our members and invited guests has always been our priority and this continues to be the case.

CMA is looking at hosting the Regulatory Forum online as a webinar.
We will update members as soon as possible regarding the date and cost of the new format for the Regulatory Forum.

CMA welcomes you to attend our Regulatory Forum, to be held on the 29th of April 2020.

The complementary medicines sector has now seen the implementation of the majority of the Medicines Reform Package (MMDR) recommendations; this changes the landscape of the regulatory framework for complementary medicines. 

Join the Forum
CMA is excited to share with you the 2020 Regulatory Forum Program; it offers an educational and informative learning environment backed by an exceptional line-up of speakers.

Topics include:

Cheryl McRea, Assistant Secretary to the Complementary and OTC Medicines Branch, Department of Health’s Therapeutic Goods Administration. Cheryl will outline the Reforms and the Regulation of Complementary Medicines, including key activities, approaches and reviews for 2020.

Dr Adam Cook, Director Listing Compliance Section, Department of Health’s Therapeutic Goods Administration, who will outline the latest updates from the post-market review section and compliance-related topics.

Ben Lazzaro, Chief Executive Officer, Australia Made Campaign, who will present opportunities resulting from the recently passed Competition and Consumer (Australian made Complementary Medicines) Regulations 2019 “Country of Origin Labelling for Complementary Medicines.”

Professor Alan Bensoussan, Director NICM Health Research Institute, who will address the new opportunities in Complementary Medicines; AUST Assessed medicines, Data Protection and TGA monograph development.

Nicholas Mercieca, Regulatory Specialist at RDC Global, who will detail the recent proposed changes to the regulation of sports supplements in Australia.

Be among the first to hear about the outcomes and opportunities of the reforms and learn about ongoing and future regulatory developments.

Click here to view the program

The team at CMA looks forward to receiving your registration and welcoming you to our 2020 Regulatory Forum.

Call us on 02 6260 4022 or fax 02 6260 4122

Address: PO Box 450 Mawson, ACT 2607 Australia

Powered by Wild Apricot Membership Software